Utah Medical Products, Inc.
UTMD
$52.30
-$0.10-0.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.60% | -9.74% | -9.39% | -4.52% | 0.98% |
| Total Depreciation and Amortization | -55.31% | -55.42% | -40.33% | -24.87% | -10.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.41% | -758.46% | -1,008.47% | -1,569.23% | -168.68% |
| Change in Net Operating Assets | -673.82% | 51.16% | 39.45% | 67.31% | 89.53% |
| Cash from Operations | -33.44% | -23.88% | -19.94% | -10.31% | 5.36% |
| Capital Expenditure | 64.01% | 47.02% | 43.49% | -0.49% | 21.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.45% | 50.77% | 46.54% | 5.29% | 21.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 233.33% | 57.26% | 83.62% | 9.09% | -32.76% |
| Repurchase of Common Stock | -- | -- | -- | -19.84% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.51% | -0.73% | -1.63% | -1.61% | -35.38% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -472.34% | -327.55% | -231.06% | -8.35% | 24.05% |
| Foreign Exchange rate Adjustments | -299.71% | -30.15% | -829.03% | 93.01% | 144.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.52% | -98.70% | -74.99% | -14.25% | 26.55% |